{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:31Z","timestamp":1786988131498,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["15ykjc08b"],"award-info":[{"award-number":["15ykjc08b"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Guangdong Provincial International Cooperation Project of Science & Technology"],"award-info":[{"award-number":["Guangdong Provincial International Cooperation Project of Science & Technology"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2013B051000038"],"award-info":[{"award-number":["2013B051000038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31371070"],"award-info":[{"award-number":["31371070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ejphar.2019.172871","type":"journal-article","created":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T02:01:28Z","timestamp":1576288888000},"page":"172871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Discovery of a novel niacin-lipoic acid dimer N2L attenuating atherosclerosis and dyslipidemia with non-flushing effects"],"prefix":"10.1016","volume":"868","author":[{"given":"Yiming","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meicun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongbiao","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172871_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3164\/jcbn.2008051","article-title":"Lipid lowering effect of antioxidant alpha-lipoic Acid in experimental atherosclerosis","volume":"43","author":"Amom","year":"2008","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2019.172871_bib2","first-page":"20","article-title":"[Importance of HDL cholesterol in atherothrombosis: how did we get here? Where are we going?]","volume":"63","author":"Badimon","year":"2010","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.ejphar.2019.172871_bib3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172871_bib4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.apsb.2018.05.006","article-title":"Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives","volume":"8","author":"Battogtokh","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2019.172871_bib5","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1124\/mol.106.030833","article-title":"Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells","volume":"70","author":"Benyo","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172871_bib6","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1172\/JCI23626","article-title":"GPR109A (PUMA-G\/HM74A) mediates nicotinic acid-induced flushing","volume":"115","author":"Benyo","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172871_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172871_bib8","first-page":"570","article-title":"Lipoic acid - the drug of the future?","volume":"57","author":"Bilska","year":"2005","journal-title":"Pharmacol. Rep. PR"},{"key":"10.1016\/j.ejphar.2019.172871_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/acs.jmedchem.5b01239","article-title":"N-benzylbenzamides: a novel merged scaffold for orally available dual soluble epoxide hydrolase\/peroxisome proliferator-activated receptor gamma modulators","volume":"59","author":"Blocher","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.172871_bib10","doi-asserted-by":"crossref","first-page":"17245","DOI":"10.3390\/ijms160817245","article-title":"Advances in the study of the antiatherogenic function and novel therapies for HDL","volume":"16","author":"Cao","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2019.172871_bib11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1368-5031.2004.00233.x","article-title":"Niaspan, the prolonged release preparation of nicotinic acid (niacin), the broad-spectrum lipid drug","volume":"58","author":"Carlson","year":"2004","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ejphar.2019.172871_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/bmc.3006","article-title":"Determination of newly synthesized lipoic acid-niacin dimer in rat plasma by UPLC\/electrospray ionization tandem mass spectrometry: assay development, validation and application to a pharmacokinetic study","volume":"28","author":"Chen","year":"2014","journal-title":"Biomed. Chromatogr. BMC"},{"key":"10.1016\/j.ejphar.2019.172871_bib13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/ATVBAHA.111.236315","article-title":"Niacin in cardiovascular disease: recent preclinical and clinical developments","volume":"32","author":"Digby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2019.172871_bib14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1194\/jlr.D071696","article-title":"Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimetics","volume":"58","author":"Dunbar","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2019.172871_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(09)61794-3","article-title":"The metabolic syndrome","volume":"375","author":"Eckel","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2019.172871_bib16","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2019.172871_bib17","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2013.06.008","article-title":"Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential","volume":"25","author":"Gaidarov","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2019.172871_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2019.172871_bib19","first-page":"e6","article-title":"Heart disease and stroke statistics--2013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2019.172871_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Group","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"8A","key":"10.1016\/j.ejphar.2019.172871_bib42","doi-asserted-by":"crossref","first-page":"20B","DOI":"10.1016\/j.amjcard.2008.02.029","article-title":"Mechanism of action of niacin","volume":"101","author":"Kamanna","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2019.172871_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172871_bib22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1517\/13543776.2014.937425","article-title":"Therapeutic applications of lipoic acid: a patent review (2011 - 2014)","volume":"24","author":"Koufaki","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejphar.2019.172871_bib23","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.2174\/092986709789878274","article-title":"Multifunctional lipoic acid conjugates","volume":"16","author":"Koufaki","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.172871_bib24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.clpt.6100180","article-title":"Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1","volume":"81","author":"Lai","year":"2007","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2019.172871_bib25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archinte.164.7.697","article-title":"New perspectives on the use of niacin in the treatment of lipid disorders","volume":"164","author":"McKenney","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2019.172871_bib26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.5551\/jat.RV17012","article-title":"Lipid lowering therapy and circulating PCSK9 concentration","volume":"24","author":"Nozue","year":"2017","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.ejphar.2019.172871_bib27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0891-5849(95)00017-R","article-title":"alpha-Lipoic acid as a biological antioxidant","volume":"19","author":"Packer","year":"1995","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.ejphar.2019.172871_bib28","first-page":"1","article-title":"alpha-Lipoic acid as a triglyceride-lowering nutraceutical","author":"Pashaj","year":"2015","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172871_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/iub.40","article-title":"Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity","volume":"60","author":"Petersen Shay","year":"2008","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ejphar.2019.172871_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.114.2952.93","article-title":"Crystalline alpha-lipoic acid; a catalytic agent associated with pyruvate dehydrogenase","volume":"114","author":"Reed","year":"1951","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2019.172871_bib31","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172871_bib32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/187153008784534303","article-title":"Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS","volume":"8","author":"Salinthone","year":"2008","journal-title":"Endocr. Metab. Immune Disord. - Drug Targets"},{"key":"10.1016\/j.ejphar.2019.172871_bib33","first-page":"1943","article-title":"Niacin for reduction of cardiovascular risk","volume":"371","author":"Santos-Gallego","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172871_bib34","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","article-title":"Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential","volume":"1790","author":"Shay","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2019.172871_bib35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/AC.71.4.3159701","article-title":"Niacin is still beneficial. Implications from an updated meta-regression analysis","volume":"71","author":"Siniawski","year":"2016","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.ejphar.2019.172871_bib36","doi-asserted-by":"crossref","first-page":"313021","DOI":"10.1155\/2015\/313021","article-title":"The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress","volume":"2015","author":"Skibska","year":"2015","journal-title":"Oxidative medicine and cellular longevity"},{"key":"10.1016\/j.ejphar.2019.172871_bib37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/01.CIR.0000153272.48711.B9","article-title":"Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study","volume":"111","author":"Sola","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2019.172871_bib38","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1074\/jbc.TM117.000259","article-title":"Lipoic acid metabolism and mitochondrial redox regulation","volume":"293","author":"Solmonson","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172871_bib39","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1161\/01.CIR.0000148955.19792.8D","article-title":"Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins","volume":"110","author":"Taylor","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2019.172871_bib40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/jcpt.12096","article-title":"A high incidence of exanthematous eruption associated with niacin\/laropiprant combination in Hong Kong Chinese patients","volume":"38","author":"Yang","year":"2013","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ejphar.2019.172871_bib41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/CIRCULATIONAHA.107.725275","article-title":"Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E\/low-density lipoprotein receptor-deficient mice","volume":"117","author":"Zhang","year":"2008","journal-title":"Circulation"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919308234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919308234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:27:19Z","timestamp":1778642839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919308234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":42,"alternative-id":["S0014299919308234"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172871","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a novel niacin-lipoic acid dimer N2L attenuating atherosclerosis and dyslipidemia with non-flushing effects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172871"}}